Lisata Therapeutics, Inc. LSTA
1.21 USD -0.07 (-5.47%)
Regular-session close
1.18 -0.03 -2.48%
Pre-market · Nov 16, 4:00 AM ET
1.20 Day range 1.26
0.96 52-week range 5.07
- YTD
- -34.95%
- 1 year
- -41.55%
Benzinga news
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Lisata Therapeutics (NASDAQ:LSTA) stock rose 37.2% to $1.4 during Wednesday's regular session. The market value of their outstanding shares is at $11.0 million. BioStem Technologies…benzinga.com Lisata’s Subsidiary Marea Therapeutics Reports Phase 2b TYDAL-TIMI 78 Data Showing Up To 72.2% Triglyceride Reduction With MAR001, Meeting All Part A Objectives Part A of TYDAL-TIMI 78 Trial met all objectives, with statistically significant placebo-adjusted triglyceride reductions of 39.1%–45.5% across all three doses at Week 12 and up to 57.2% in…
